0001140361-18-008303.txt : 20180214 0001140361-18-008303.hdr.sgml : 20180214 20180214170813 ACCESSION NUMBER: 0001140361-18-008303 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20171231 FILED AS OF DATE: 20180214 DATE AS OF CHANGE: 20180214 EFFECTIVENESS DATE: 20180214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarissa Capital Management LP CENTRAL INDEX KEY: 0001577524 IRS NUMBER: 900924432 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-15935 FILM NUMBER: 18613477 BUSINESS ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 BUSINESS PHONE: 203-302-2330 MAIL ADDRESS: STREET 1: 660 STEAMBOAT ROAD CITY: GREENWICH STATE: CT ZIP: 06830 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001577524 XXXXXXXX 12-31-2017 12-31-2017 Sarissa Capital Management LP
660 STEAMBOAT ROAD GREENWICH CT 06830
13F HOLDINGS REPORT 028-15935 N
Alexander J. Denner, Ph.D. Chief Investment Officer 203-302-2330 /s/ Alexander J. Denner Greenwich CT 02-14-2018 0 11 390650 false
INFORMATION TABLE 2 form13fInfoTable.xml ABBVIE INC. COM 00287Y109 967 10000 SH SOLE 10000 0 0 ACHILLION PHARMACEUTICALS INC COM 00448Q201 7200 2500000 SH SOLE 2500000 0 0 ALLERGAN PLC SHS G0177J108 42089 257300 SH SOLE 257300 0 0 APRICUS BIOSCIENCES INC COM NEW 03832V307 2664 1447906 SH SOLE 1447906 0 0 BIOGEN INC COM 09062X103 131842 413858 SH SOLE 413858 0 0 BIOVERATIV INC COM 09075r100 62816 1165000 SH SOLE 1165000 0 0 INNOVIVA INC COM 45781M101 51945 3600705 SH SOLE 3600705 0 0 INTERCEPT PHARMACEUTICALS INC COM 45845P108 10649 182300 SH SOLE 182300 0 0 IRONWOOD PHARMACEUTICALS INC. COM CLA 46333X108 24733 1650000 SH SOLE 1650000 0 0 MEDICINES CO COM 584688105 52547 1922000 SH SOLE 1922000 0 0 NOVELION THERAPEUTICS INC COM NEW 67001K202 3198 1025000 SH SOLE 1025000 0 0